Article

Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene.

Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Molecular and Cellular Biology (Impact Factor: 5.04). 10/1999; 19(9):6318-22.
Source: PubMed

ABSTRACT The constitutively active receptor (CAR) transactivates a distal enhancer called the phenobarbital (PB)-responsive enhancer module (PBREM) found in PB-inducible CYP2B genes. CAR dramatically increases its binding to PBREM in livers of PB-treated mice. We have investigated the cellular mechanism of PB-induced increase of CAR binding. Western blot analyses of mouse livers revealed an extensive nuclear accumulation of CAR following PB treatment. Nuclear contents of CAR perfectly correlate with an increase of CAR binding to PBREM. PB-elicited nuclear accumulation of CAR appears to be a general step regulating the induction of CYP2B genes, since treatments with other PB-type inducers result in the same nuclear accumulation of CAR. Both immunoprecipitation and immunohistochemistry studies show cytoplasmic localization of CAR in the livers of nontreated mice, indicating that CAR translocates into nuclei following PB treatment. Nuclear translocation of CAR also occurs in mouse primary hepatocytes but not in hepatocytes treated with the protein phosphatase inhibitor okadaic acid. Thus, the CAR-mediated transactivation of PBREM in vivo becomes PB responsive through an okadaic acid-sensitive nuclear translocation process.

0 Followers
 · 
112 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: HR96 is a CAR/PXR/VDR ortholog in invertebrates, and a promiscuous endo- and xenobiotic nuclear receptor involved in acclimation to toxicants. Daphnia HR96 is activated by chemicals such as atrazine and linoleic acid (LA) (n-6 fatty acid), and inhibited by triclosan and docosahexaenoic acid (DHA) (n-3 fatty acid). We hypothesized that inhibitors of HR96 may block the protective responses of HR96 based on previously performed luciferase assays. Therefore, we performed acute toxicity tests with two-chemical mixtures containing a HR96 inhibitor (DHA or triclosan) and a HR96 activator (LA or atrazine). Surprisingly, results demonstrate that triclosan and DHA are less toxic when co-treated with 20-80μM atrazine. Atrazine provides concentration-dependent protection as lower concentrations have no effect and higher concentrations cause toxicity. LA, a weaker HR96 activator, did not provide protection from triclosan or DHA. Atrazine's protective effects are presumably due to its ability to activate HR96 or other toxicologically relevant transcription factors and induce protective enzymes. Atrazine did not significantly induce glucosyltransferase, a crucial enzyme in triclosan detoxification. However, atrazine did increase antioxidant activities, crucial pathways in triclosan's toxicity, as measured through GST activity and the TROLOX equivalence assay. The increase in antioxidant capacity is consistent with atrazine providing protection from a wide range of toxicants that induce ROS, including triclosan and unsaturated fatty acids predisposed to lipid peroxidation. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Chemosphere 03/2015; 128C:299-306. DOI:10.1016/j.chemosphere.2015.02.027 · 3.50 Impact Factor
  • Chapter: Liver
    Principles of Tissue Engineering, 3rd edited by R. Lanza, R. Langer, J.P. Vacanti, 01/2007: chapter Chapter 48: Liver: pages 707-732; Elsevier.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Numerous experimental, clinical and epidemiological studies show that exposure to environmental contaminants may disrupt endocrine and metabolic functions of our organism. This would contribute to the development of obesity and associated metabolic disorders such as nonalcoholic hepatic steatosis, characterized by an excessive accumulation of triglycerides in the liver, which may lead to more severe forms of NAFLD (Non-Alcoholic Fatty Liver Diseases) such as inflammation, fibrosis, cirrhosis and hepatocellular carcinoma. In this work, in vivo studies have highlighted that chronic exposure to the xenoestrogen BPA, widely used in plastic food packaging industry, affects hepatic energy metabolism. It promotes the storage of triglycerides and cholesterol ester in the liver, in association with the induction of the hepatic transcriptome, more particularly of genes involved in lipid, carbohydrates and cholesterol synthesis. These effects, which could contribute to promote hepatic steatosis, follow an inverted U shape non-monotonic dose-response curve and were observed below the reference dose in regulatory toxicology: the tolerable daily intake. These results strengthen the idea that BPA act as a metabolic disruptor, particularly at low doses. Nuclear receptors are targets through which metabolic disruptors may influence gene expression. Recent studies showed that the nuclear receptors CAR (Constitutive Receptor Androstane) and PXR (Pregnane X Receptor), initially identified as key receptors of the detoxification process, are also involved in the regulation of energy metabolism. We identified the gene coding for adiponutrin/PNPLA3 (Patatin-like phospholipase domain-containing) as a new target of these xenosensors. We have shown with transgenic animal models and with hepatocyte cell lines that the CAR and PXR receptors regulate the Pnpla3 gene expression. This protein has a central role in hepatic lipid metabolism through its dual transacylase and lipase activity. In human, a variant of the Pnpla3 (SNP I148M) gene has been identified as a new marker of hepatic steatosis and is associated with an increased risk of NAFLD. Since the xenosensors CAR and PXR are known to be activated by many drugs and environmental pollutants, our results highlight the risk of a development of hepatic steatosis after their activation. Taken together, these results highlight the risk of metabolic disruptions after exposure to various environmental contaminants such as endocrine disruptors and CAR activators. RÉSUMÉ De nombreuses études expérimentales, cliniques et épidémiologiques récentes montrent que l’exposition à des contaminants de notre environnement pourrait perturber les fonctions métaboliques et endocriniennes des organismes. Ceci contribuerait au développement de l'obésité et des pathologies métaboliques associées telles que la stéatose hépatique non alcoolique, caractérisée par une accumulation massive de triglycérides dans le foie, et qui est susceptible d’évoluer vers des pathologies plus sévères (inflammation, fibrose, cirrhose, carcinome hépatocellulaire), regroupées sous le terme de NAFLD (Non- Alcoholic Fatty Liver Diseases). Nos études réalisées chez le rongeur nous ont permis de mettre en évidence un impact sur le métabolisme hépatique suite à une exposition chronique au Bisphénol A (BPA), un contaminant oestrogéno-mimétique largement exploité dans l’industrie des emballages alimentaires plastiques. Il modifie l’expression des gènes impliqués dans la synthèse des lipides, des glucides et du cholestérol et favorise l’accumulation de triglycérides et d’esters de cholestérol au niveau hépatique. Ces effets, qui pourraient contribuer à l’émergence de la stéatose hépatique, ont été observés en deçà de la dose de référence en toxicologie réglementaire (la dose journalière admissible) et suivent une courbe dose-réponse non monotone en U inversé. Ces résultats renforcent l’idée que le BPA est un perturbateur métabolique, surtout lors d’expositions à faibles doses. Les récepteurs nucléaires représentent des cibles potentielles des perturbateurs métaboliques. Plusieurs études récentes montrent que les récepteurs nucléaires CAR (Constitutive Androstane Receptor) et PXR (Pregnane X Receptor), initialement identifiés comme des récepteurs clés du système de détoxification, sont également impliqués dans la régulation du métabolisme énergétique. Nos travaux ont permis d’identifier une nouvelle cible de ces xénosenseurs : le gène codant pour l’adiponutrine/PNPLA3 (Patatinlike phospholipase domain-containing). Nous avons montré, in vivo et sur des lignées d'hépatocytes en culture, que les récepteurs CAR et PXR régulent l’expression du gène Pnpla3. Cette protéine présente une activité à la fois transacylase et lipase qui lui confère un rôle central dans la régulation du métabolisme lipidique hépatique. Chez l’Homme, un variant du gène Pnpla3 (SNP I148M) a été identifié comme un nouveau marqueur de la stéatose hépatique et est associé à un risque accru de développement de NAFLD. Les xénosenseurs CAR et PXR étant activés par de nombreux médicaments et polluants environnementaux, nos résultats mettent en exergue le risque de développement de stéatoses hépatiques suite à leur activation. L’ensemble de ces résultats renforce l’idée d’un risque de développement de pathologies métaboliques suite à l’exposition à différents contaminants environnementaux, qu’il s’agisse de perturbateurs endocriniens de type métaboliques ou d’activateurs des xénosenseurs CAR et PXR.
    12/2012, Degree: PhD, Supervisor: Dr Laila MSELLI-LAKHAL ; Dr Thierry PINEAU

Full-text (2 Sources)

Download
33 Downloads
Available from
May 22, 2014